Potential risks of Bipolar Disorder

 

qEEG screening

Service code s9022

Please note that screening does NOT result in a medical diagnosis; it gives a probabilistic estimate of risk. In other words, the screening gives information on the presence of a pattern in the qEEG that is often – but not always – found in persons with a history of a particular condition.

Short description

Bipolar disorder is characterized by a hypersensitivity to reward-relevant cues and a propensity to experience an excessive increase in approach-related affect.

Since symptoms of bipolar disorder often overlap with several other disorders, a qEEG may offer additional neurophysiological information – a so-called “signature” for bipolar disorder, and can provide further understanding of pathophysiological mechanisms underlying this mental disorder.

Results

By performing this qEEG screening you will get the information on:

  • whether you have a qEEG pattern typical for bipolar disorder and
  • the potential extent of its severity.

Notes:

  • The results of qEEG analysis are put in context of published scientific studies, the individual’s health history, complaints, symptoms and psychometric and other evaluations (if available).
  • Present psychotropic medication use may affect the results.

To place a service order, use the following email: This email address is being protected from spambots. You need JavaScript enabled to view it. (you may bundle several services in the same order).

 

References

  1. Cook BL, Shukla S, Hoff AL. EEG abnormalities in bipolar affective disorder. J Affect Disord 1986; 11: 147–149.
  2. Metin SZ, Erguzel TT, Ertan G, Salcini C, Kocarslan B, Cebi M, Metin B, Tanridag O, Tarhan N. The use of quantitative EEG for differentiating frontotemporal dementia from late-onset bipolar disorder. Clinical EEG and Neuroscience 2018; 1–6.
  3. Yasin S, Hussain SA, Aslan S, Raza I, Muzammel M, Othmani A. EEG based Major Depressive disorder and Bipolar disorder detection using Neural Networks: A review. Computer Methods and Programs in Biomedicine 2021; 202: 106007.